(Q39851827)

15 September 2017

title

Additive effects of 5-aza-2'-deoxycytidine and irradiation on clonogenic survival of human medulloblastoma cell lines (English)

1 reference

15 September 2017

0 references

Ina Patties

1

1 reference

15 September 2017

Jutta Jahns

2

1 reference

15 September 2017

Guido Hildebrandt

3

1 reference

15 September 2017

Rolf-Dieter Kortmann

4

1 reference

15 September 2017

Annegret Glasow

5

1 reference

15 September 2017

publication date

15 May 2009

1 reference

Strahlentherapie und Onkologie

15 September 2017

published in

1 reference

15 September 2017

volume

185

1 reference

15 September 2017

issue

5

1 reference

15 September 2017

page(s)

331-338

1 reference

Pathogenesis of medulloblastoma and current treatment outlook.

15 September 2017

cites work

1 reference

12 December 2020

MethPrimer: designing primers for methylation PCRs

1 reference

12 December 2020

Enhancement of radiation sensitivity of human squamous carcinoma cells by histone deacetylase inhibitors

1 reference

12 December 2020

Dickkopf-1 is an epigenetically silenced candidate tumor suppressor gene in medulloblastoma

1 reference

12 December 2020

Promoter methylation status of multiple genes in brain metastases of solid tumors.

1 reference

12 December 2020

Identification of tumour-specific epigenetic events in medulloblastoma development by hypermethylation profiling

1 reference

12 December 2020

Induction of gene expression by 5-Aza-2'-deoxycytidine in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) but not epithelial cells by DNA-methylation-dependent and -independent mechanisms

1 reference

12 December 2020

Modulation of cellular radiation responses by histone deacetylase inhibitors

1 reference

12 December 2020

Plasma and cerebrospinal fluid pharmacokinetics of 5-Aza-2'-deoxycytidine in rabbits and dogs

1 reference

12 December 2020

High sensitivity mapping of methylated cytosines

1 reference

12 December 2020

Retinoids and myelomonocytic growth factors cooperatively activate RARA and induce human myeloid leukemia cell differentiation via MAP kinase pathways

1 reference

12 December 2020

Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity

1 reference

12 December 2020

Phase I trial of continuous infusion 5-aza-2'-deoxycytidine

1 reference

12 December 2020

Epigenetic deregulation of multiple S100 gene family members by differential hypomethylation and hypermethylation events in medulloblastoma

1 reference

12 December 2020

A pharmacodynamic study of 5-azacytidine in the P39 cell line

1 reference

12 December 2020

HDAC inhibitors act with 5-aza-2'-deoxycytidine to inhibit cell proliferation by suppressing removal of incorporated abases in lung cancer cells

1 reference

12 December 2020

Helical tomotherapy. Experiences of the first 150 patients in Heidelberg

1 reference

12 December 2020

The role of decitabine in the treatment of myelodysplastic syndromes

1 reference

12 December 2020

DNA methylation inhibitor 5-Aza-2'-deoxycytidine induces reversible genome-wide DNA damage that is distinctly influenced by DNA methyltransferases 1 and 3B.

1 reference

12 December 2020

Combined postoperative irradiation and chemotherapy for anaplastic ependymomas in childhood: results of the German prospective trials HIT 88/89 and HIT 91.

1 reference

12 December 2020

Pilot phase I-II study on 5-aza-2'-deoxycytidine (Decitabine) in patients with metastatic lung cancer

1 reference

12 December 2020

Evaluation of a 7-day continuous intravenous infusion of decitabine: inhibition of promoter-specific and global genomic DNA methylation

1 reference

12 December 2020

Quantitative analysis of promoter hypermethylation in multiple genes in osteosarcoma.

1 reference

12 December 2020

[Current and future strategies in interdisciplinary treatment of medulloblastomas, supratentorial PNET (primitive neuroectodermal tumors) and intracranial germ cell tumors in childhood]

1 reference

12 December 2020

Demethylating agent 5-aza-2'-deoxycytidine enhances susceptibility of renal cell carcinoma to paclitaxel

1 reference

12 December 2020

Acute neurocognitive impairment during cranial radiation therapy in patients with intracranial tumors

1 reference

12 December 2020

Phase I trial of sequential low-dose 5-aza-2'-deoxycytidine plus high-dose intravenous bolus interleukin-2 in patients with melanoma or renal cell carcinoma.

1 reference

12 December 2020

Medulloblastoma in childhood: new biological advances

1 reference

12 December 2020

Epigenetic silencing of telomerase and a non-alkylating agent as a novel therapeutic approach for glioma

1 reference

12 December 2020

Characterization of DNA demethylation effects induced by 5-Aza-2'-deoxycytidine in patients with myelodysplastic syndrome.

1 reference

12 December 2020

Epigenetics in human disease and prospects for epigenetic therapy

1 reference

12 December 2020

Gene transcripts as potential diagnostic markers for allergic contact dermatitis.

1 reference

12 December 2020

Enhanced sensitivity of prostate cancer DU145 cells to cisplatinum by 5-aza-2'-deoxycytidine.

1 reference

12 December 2020

Novel technique of craniospinal axis proton therapy with the spot-scanning system: avoidance of patching multiple fields and optimized ventral dose distribution.

1 reference

12 December 2020

Deregulation of caspase 8 and 10 expression in pediatric tumors and cell lines.

1 reference

12 December 2020

Demethylating agent 5-aza-2'-deoxycytidine enhances susceptibility of bladder transitional cell carcinoma to Cisplatin

1 reference

12 December 2020

DNA hypermethylation at the D17S5 locus and reduced HIC-1 mRNA expression are associated with hepatocarcinogenesis.

1 reference

12 December 2020

Inactivation of RAS association domain family 1A gene in cervical carcinomas and the role of human papillomavirus infection

1 reference

12 December 2020

Biallelic epigenetic inactivation of the RASSF1A tumor suppressor gene in medulloblastoma development.

1 reference

12 December 2020

Phase I and pharmacodynamic trial of the DNA methyltransferase inhibitor decitabine and carboplatin in solid tumors

1 reference

12 December 2020

Intracerebral cavernous hemangioma after cranial irradiation in childhood. Incidence and risk factors

1 reference

12 December 2020

10.1007/S00066-009-1956-1

Identifiers

DOI

1 reference

release_erl7jd4lgzbahntyxjvlokbqh4

15 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/erl7jd4lgzbahntyxjvlokbqh4

24 November 2022

mapped directly with Wikidata item

1 reference